Details of the Drug
General Information of Drug (ID: DMMYQ9R)
Drug Name |
2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole; 31659-42-4; 1h-imidazole, 4,5-dihydro-2-(3-nitrophenyl)-; CHEMBL457101; 4,5-Dihydro-2-(3-nitrophenyl)-1H-imidazole; EINECS 250-754-1; AC1LEYVJ; AC1Q1ZUC; 2-(m-nitrophenyl)imidazoline; IMI021; SCHEMBL12643294; CTK4G7541; DTXSID30185551; MolPort-006-126-327; ZINC121568; 2-(3-Nitrophenyl)-2-imidazoline; STK367845; BDBM50266032; BBL001160; AKOS005444754; MCULE-9494328291; T7684
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 191.19 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||